These findings, together with those from UBQLN2-related ALS/FTD models (Fig. 7, E and F), indicate that the therapeutic benefit of autophagy induction is apparent in some, but not all disease contexts. Here, UBQLN2 is linked to amyotrophic lateral sclerosis.